English
|
ÖÐÎÄ
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
High-Throughput Testing Reveals Genetic Programs, Pathogenic Variants in Neurodegenerative Disease
2022-08-22
Researchers at the University of California, Los Angeles have identified noncoding genetic regulatory elements that impact the risk of dementia from Alzheimer's disease and the pathologically related progressive supranuclear palsy (PSP).
New blood screening solution Cobas ® MPX launched by Roche Diagnostics in China
2022-08-19
As an important medical resource to save lives, blood safety is very important and blood screening is the most critical link to ensure blood safety.
Autism Spectrum Disorder Studies Uncover Additional Genetic Risk Variants
2022-08-19
A pair of new studies examines genetic variations that confer risk of developing autism spectrum disorder, providing insight into the different phenotypes associated with the disorder.
CorDx Gets CE-IVD Marks for Monkeypox Assays
2022-08-19
San Diego-based diagnostics firm CorDx said on Thursday that it has obtained CE-IVD marks for a PCR test and a lateral flow test for monkeypox.
AutoBio achieved 29.28% increase in the first half of the year
2022-08-18
On August 17, AutoBio Diagnostics released its first-half results of 2022. The company achieved CNY 2.070 billion revenue by the end of June, with a year-on-year increase of 23.41%. The net profit attributable to shareholders was CNY 534 million, increasing 29.28% than the last year.
Eurobio Scientific to Acquire GenDx for €135M in Cash
2022-08-18
French diagnostics firm Eurobio Scientific said on Wednesday that it has agreed to acquire Genome Diagnostics, also known as GenDx, for €135 million ($137.2 million) in cash.
Agilent Fiscal Q3 Revenues up 8 Percent, Beat Analyst Estimate
2022-08-18
Agilent Technologies announced after the close of the market Tuesday that its fiscal third quarter revenues grew 8 percent year over year, topping the consensus Wall Street estimate.
Get four certifications in a row! Tianlong Science and Technology E. coli and other nucleic acid kits obtained CE certification and entered the EU market!
2022-08-17
Recently, four products of Tianlong Science and Technology, including E. coli, Salmonella, Staphylococcus aureus, and Listeria monocytogenes DNA detection kits, have obtained EU CE certification.
Illumina, Minderoo Foundation Ink A$40M Partnership on Marine Life Sequencing
2022-08-17
Illumina and the Minderoo Foundation said on Tuesday that they have signed a partnership to commit A$40 million ($27.8 million) towards sequencing DNA in marine systems.
Ginkgo Bioworks Reports Q2 Revenues More Than Triple, Raises Guidance
2022-08-17
Ginkgo Bioworks reported after the close of the market on Monday that its second quarter 2022 revenues grew 231 percent year over year, driven by biosecurity service revenues.
Roche and AmoyDx reached a strategic cooperation
2022-08-16
August 11, the Second Roche Pan-Tumor Precision Diagnosis and Innovation Ecology Forum was officially opened at Roche Pharma China Shanghai Campus, where participants discussed solutions for pan-tumor precision diagnosis and treatment.
Becton Dickinson to Offer Accelerate Diagnostics AST Systems Under Collaboration
2022-08-16
Becton Dickinson announced on Monday that it has inked a deal with Accelerate Diagnostics to sell that firm's Accelerate Pheno system and the Accelerate Arc module for antimicrobial susceptibility testing.
Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
2022-08-16
The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100 percent of Albumedix Ltd. from private investors.
KingMed & Cepheid China are joining forces to jointly promote accurate diagnosis of infectious diseases!
2022-08-15
Kingmed and Cephei China dsigned a strategic cooperation agreement in Guangzhou to jointly promote the accurate diagnosis of clinical infectious diseases such as tuberculosis, hospital-acquired infection, drug-resistant bacterial infection, and carry out long-term in-depth cooperation.
Guardant Health, Thermo Fisher Scientific Tests Approved as CDx to Enhertu in Lung Cancer
2022-08-15
Guardant Health and Thermo Fisher Scientific said on Friday that the US Food and Drug Administration has granted premarket approvals for their respective next-generation sequencing assays as companion diagnostics to Enhertu (trastuzumab deruxtecan)
Total:
3517
Pages:
235
First
Prev
1
..
122
123
124
125
126
127
128
..
235
Next
End